The human CD44 gene encodes a family of cell surface glycoproteins which are involved in diverse intra-and extracellular functions. Abnormal expression of this locus has been observed in neoplasia in several organs and there is also evidence suggesting that it may play a role in tumour metastasis. ' The gene is composed of a stretch of approximately 60 kilobases on chromosome ulp, comprising at least 21 exons. Ten of these (that is, exons 1-5 and 16-20) are expressed together on all cell types as the standard form (CD44s) and the remaining 11 can be included by alternative splicing to generate a number of variant isoforms (CD44v).2 The regulation of expression of the CD44v isoforms is unknown but data from several laboratories now confirm that the overproduction of protein isoforms and of many transcripts, including immature cytoplasmic mRNA species containing introns, is associated with the onset and progression of tumours in many organs. 3 This information has been obtained by a combination of techniques including immunohistochemistry4 and reverse transcription followed by the polymerase chain reaction (RT-PCR).5-8 However, although the former gives information regarding the distribution of CD44 proteins and the latter gives an insight into differences in relative levels of the transcription of the gene in normal and tumour tissues, neither can be used to view the cellular distribution of CD44 transcripts. single blocks from five separate cases of colonic carcinoma, four from breast carcinomas and two from carcinomas of the uterine cervix. Four further blocks from normal cervical tissue were also studied.
IN SITU HYBRIDISATION
In situ hybridisation was carried out using a modification of the method described by Sim- Slides were hand-dipped in Kodak NTB-2 emulsion and then exposed at 4°C for two weeks. After developing, sections were stained with haematoxylin and eosin, mounted and photographed.
PREPARATION OF RNA PROBES FOR IN SITU HYBRIDISATION
35S labelled riboprobes for CD44 standard and variant transcript detection were synthesised as described previously.9
Results
The observations described below were reproducible in all specimens in each category. In all the normal breast tissue specimens, weak signals for both CD44s and CD44v could be seen over the luminal epithelial cells as well as over the myoepithelial cells. The CD44s probe also hybridised to the cells in the surrounding stroma but the one for CD44v did not do so above background level (figs 2A and 2B) . In contrast, both probes showed marked elevation of signal intensity over the carcinoma cells in these sections but the one for CD44v hybridised only with carcinoma cells and not with stromal cells in all tumours studied. This therefore provided a clear demonstration that the abnormally high levels of alternatively spliced CD44v gene transcripts detected previously by RT-PCR in tumours are located specifically in the carcinoma cells.
TISSUES FROM THE CERVIX UTERI
In normal cervical squamous epithelium both standard and alternatively spliced CD44 transcripts were most prevalent in the basal layer and declined substantially in the adjacent overlying layers ( figs 2C and 2D) . Interestingly, the CD44v signal was significantly greater than that of CD44s over this type of epithelium. In the specimens of cervical carcinomas this technique indicated that the transcripts for both CD44s and CD44v were increased in the carcinoma cells relative to others. The intensity of the CD44v signal was higher than that of CD44s over the malignant epithelium and it was absent over the stromal and inflammatory cells (figs 2E and 2F group.bmj.com on June 16, 2017 -Published by http://mp.bmj.com/ Downloaded from pathological specimens. As in the previous study of frozen tissue,9 it was shown that the changes are localised within the carcinoma cells. With this method it now becomes possible to conduct correlated investigations on adjacent histological sections from specifically selected archival tissue specimens to analyse relations between CD44 gene transcription and translation in pre-neoplastic lesions and during tumour progression. From such work it is hoped to build a better understanding of when the marked abnormalities in CD44 gene expression in neoplasia begin, how they inter-relate with each other and whether any of them could be used as a simple diagnostic or prognostic tool in clinical practice. The application of such techniques to archival material will be particularly suitable for the investigation of pathological conditions which are in themselves believed to be non-neoplastic for example, atypical ductal hyperplasia of the breast, but which signal an increased risk of developing invasive malignancy at some future date. These lesions, being microscopic and impalpable, are discovered as incidental findings in specimens resected for other purposes and it is therefore advantageous to study them in selected specimens, chosen from the departmental archives. At present, there is no way to identify which of the patients found to have these risk related lesions will later develop malignant tumours. It is hoped that the ability to investigate conveniently the status of transcription and translation of CD44 and other genes in histological sections may uncover a marker or a group of markers which could be helpful in the evaluation of prognosis in patients with such lesions.
